iLite® ADCC Target mVEGF (+) Assay Ready Cells can be used for assessing the possibility of an anti-VEGF antibody drug inducing ADCC. iLite mVEGF (+) Target Assay Ready Cells are based on a human embryonic kidney cell line, HEK2931 (ATCC# CRL-1573), and have been genetically engineered and optimized to express high and constant levels of membrane bound VEGF. The cells are to be used as target cells together with iLite® ADCC Effector (V) Assay Ready Cells for measuring the ADCC activity of anti-VEGF antibodies. * The HEK-293 cell line has been used under a license obtained from AdVec Inc. FOR RESEARCH USE ONLY.